Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 6, 2006

Affymetrix and NimbleGen Systems Enter into Licensing Agreement

  • NimbleGen Systems obtained a nonexclusive, worldwide license to a number of Affymetrix patents covering the manufacture, use, and sales of nucleic acid microarrays and related products and services in the research field.

    “This licensing agreement with NimbleGen follows from a commercial relationship and enables both companies to better serve customers within the growing microarray market,” says Alan Sherr, vp and chief counsel for licensing at Affymetrix.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »